Related Experiment Video
Updated: May 17, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial
Marco Ranucci1, Ekaterina Baryshnikova, Giulia Beatrice Crapelli
1Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy. cardioanestesia@virgilio.it
Preoperative purified antithrombin supplementation in cardiac surgery effectively prevents heparin resistance and maintains adequate antithrombin activity levels postoperatively, improving patient outcomes.
Area of Science:
- Cardiology
- Anesthesiology
- Hematology
Background:
- Heparin resistance and thromboembolic complications are risks in cardiac surgery.
- Purified antithrombin supplementation is a potential treatment strategy.
Purpose of the Study:
- To evaluate the efficacy of preoperative purified antithrombin supplementation.
- Primary endpoint: avoiding low postoperative antithrombin activity (<58%).
- Secondary endpoints: preventing heparin resistance, assessing clinical outcomes and safety.
Main Methods:
- A randomized controlled trial involving 200 patients undergoing cardiac surgery.
- Patients were allocated to either the antithrombin group (received supplementation) or the control group.
- Antithrombin group received a dose to achieve 120% activity.
Main Results:
- Antithrombin group maintained significantly higher postoperative antithrombin activity.
- Zero incidence of antithrombin activity <58% in the antithrombin group vs. 26.6% in controls (P=.001).
- Heparin resistance was significantly lower in the antithrombin group (17%) vs. controls (38.2%) (P=.001).
- Slightly increased bleeding (8 mL/hour) in the antithrombin group, with no difference in transfusion rates.
- No significant differences in clinical outcomes or safety concerns were observed.
Conclusions:
- Preoperative antithrombin supplementation is effective in preventing heparin resistance.
- It successfully avoids excessive postoperative decreases in antithrombin activity.
- This strategy offers a safe approach to managing antithrombin levels during cardiac surgery.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy VII: Pre and Post Operative Nursing Management